Alethios Launches AI Platform to Simplify Human Health Research
Alethios has officially launched its software platform aimed at making structured human health research accessible to a broader range of users, announced in a press release. The platform enables researchers—from biotech companies to citizen scientists—to design and execute studies using integrated data sources including self-reported outcomes, wearable sensors, and at-home biomarker kits.
Founded in 2023 by CEO Zeenia Framroze, Alethios offers two main tools: the Study Planner and Study Operator. The Study Planner allows users to design decentralized studies, digitize existing protocols, and generate recruitment materials in minutes using a generative AI feature called AI QuickStart. The Study Operator automates study logistics, participant management, and reporting through the Alethiad Participant Community.
Researchers can begin with a seven-day free trial and then continue using the platform for $100 per month. According to the company, studies built with Alethios have achieved participant adherence rates above 90% and reduced recruitment timelines to as little as three to four weeks.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Healthee Plans Zoe Access Across AI Agents by 2027
Illumina Launches BioInsight Platform for Genomic Research
Elsevier Pledges 4,000 AI Tool Licenses for European Researchers
AskELIE Opens Operational AI Platform to Customers and Partners
SPHERE HEALTH Opens Early Access to AI Hormonal Care Platform
Daily AI Brief: the AI news that matters, in your inbox.